| Product NDC: | 51672-2030 |
| Proprietary Name: | Oxymetazoline Hydrochloride |
| Non Proprietary Name: | Oxymetazoline Hydrochloride |
| Active Ingredient(s): | .05 g/100mL & nbsp; Oxymetazoline Hydrochloride |
| Administration Route(s): | NASAL |
| Dosage Form(s): | SPRAY |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51672-2030 |
| Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20060225 |
| Package NDC: | 51672-2030-3 |
| Package Description: | 1 BOTTLE, SPRAY in 1 CARTON (51672-2030-3) > 30 mL in 1 BOTTLE, SPRAY |
| NDC Code | 51672-2030-3 |
| Proprietary Name | Oxymetazoline Hydrochloride |
| Package Description | 1 BOTTLE, SPRAY in 1 CARTON (51672-2030-3) > 30 mL in 1 BOTTLE, SPRAY |
| Product NDC | 51672-2030 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Oxymetazoline Hydrochloride |
| Dosage Form Name | SPRAY |
| Route Name | NASAL |
| Start Marketing Date | 20060225 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Substance Name | OXYMETAZOLINE HYDROCHLORIDE |
| Strength Number | .05 |
| Strength Unit | g/100mL |
| Pharmaceutical Classes |